Compound Detail
CHEMBL347245
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc2c(cc1OC)CN(CCc1ccc(NC(=O)c3ccccc3NC(=O)c3cnc4ccccc4n3)cc1)CC2
Basic Information
| ChEMBL ID | CHEMBL347245 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | WZBUOTYBWCZPCQ-UHFFFAOYSA-N |
2
Targets
2
Activities
2
Assay Types
0
PK Parameters
2
Publications
0
Known Names
Molecular Properties
587.7
MW (Da)
5.75
ALogP
7
HBA
2
HBD
105.7
PSA (Ų)
0.23
QED
2
Ro5 Violations
9
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.72
IC50 1 meas. best 7.04
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| MDR | EC50 | = | 19.0 | nM | 7.72 | Potency tested against multidrug resistance (MDR) cell lines expressing P-gp (P-... | 10098671 |
| EMT6 | IC50 | = | 92.0 | nM | 7.04 | Reversal effect on the accumulation of [3H]- daunorubicin in mouse mammary carci... | 10098671 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 10098671 | 10.1016/s0960-894x(99)00030-x | EMT6 | 1 |
| 10098671 | 10.1016/s0960-894x(99)00030-x | MDR | 1 |
Data from ChEMBL 36 via Core Engine